23-Jan-2026
CareCloud's Wellsoft Ranked #1 EHR by Black Book 2026 for Emergency Medicine
Globe Newswire (Thu, 22-Jan 8:00 AM ET)
CareCloud Announces Preferred Stock Dividend Payments
Globe Newswire (Tue, 20-Jan 8:00 AM ET)
Globe Newswire (Thu, 8-Jan 8:00 AM ET)
Globe Newswire (Mon, 29-Dec 8:00 AM ET)
Globe Newswire (Mon, 15-Dec 8:00 AM ET)
Globe Newswire (Mon, 10-Nov 8:00 AM ET)
CareCloud Lifts 2025 Outlook and Accelerates AI Strategy Amid Strong Profitability
Market Chameleon (Thu, 6-Nov 5:34 AM ET)
CareCloud Reports Third Quarter 2025 Results
Globe Newswire (Thu, 6-Nov 7:00 AM ET)
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
Carecloud trades on the NASDAQ stock market under the symbol CCLD.
As of January 23, 2026, CCLD stock price declined to $2.90 with 266,977 million shares trading.
CCLD has a beta of 2.28, meaning it tends to be more sensitive to market movements. CCLD has a correlation of 0.16 to the broad based SPY ETF.
CCLD has a market cap of $122.95 million. This is considered a Micro Cap stock.
Last quarter Carecloud reported $31 million in Revenue and $.10 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.02.
In the last 3 years, CCLD traded as high as $4.84 and as low as $.68.
The top ETF exchange traded funds that CCLD belongs to (by Net Assets): VTI, AVUV, VXF, BSVO, IWC.
CCLD has underperformed the market in the last year with a price return of -10.5% while the SPY ETF gained +14.2%. CCLD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.4% and -4.9%, respectively, while the SPY returned +2.9% and -0.7%, respectively.
CCLD support price is $2.98 and resistance is $3.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CCLD shares will trade within this expected range on the day.